Lucid Diagnostics (LUCD) Current Assets (2020 - 2026)

Lucid Diagnostics has reported Current Assets for 7 years, with the latest figure at $31.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 13.89% year-over-year to $31.4 million; the trailing twelve-month figure through Mar 2026 stood at $31.4 million (up 13.89% YoY), and the FY2025 full-year result was $37.5 million, up 48.99% from the prior year.
• Current Assets for Q1 2026 stood at $31.4 million, down from $37.5 million in the prior quarter.
• The five-year high for Current Assets was $52.3 million in Q1 2022, with the low at $16.8 million in Q3 2024.
• Historically, Current Assets has averaged $32.2 million across 5 years, with a median of $29.8 million in 2022.
• The largest YoY upside for Current Assets was 1091.73% in 2022 against a maximum downside of 57.5% in 2022.
• Lucid Diagnostics' Current Assets stood at $24.4 million in 2022, then declined by 9.37% to $22.1 million in 2023, then advanced by 13.93% to $25.1 million in 2024, then surged by 48.99% to $37.5 million in 2025, then declined by 16.3% to $31.4 million in 2026.
• The last three Current Assets figures came in at $31.4 million (Q1 2026), $37.5 million (Q4 2025), and $49.8 million (Q3 2025), per Business Quant data.